After years of being a rare spot of universal, American-government-funded health care, this fall’s new COVID-19 vaccine is hitting the commercial market for the first time. So far, the rollout has been mired by hiccups and confusion. 

Guest: Jen Kates, senior vice president at KFF

If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.

Podcast production by Evan Campbell and Anna Philips.

Learn more about your ad choices. Visit megaphone.fm/adchoices